Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 222,877,235 papers from all fields of science
Search
Sign In
Create Free Account
AZD2563
Known as:
AZD 2563
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Narrower (1)
AZD5847
Broader (2)
Oxazolidinones
Posizolid
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
AZD2563, a novel oxazolidinone: definition of antibacterial spectrum, assessment of bactericidal potential and the impact of miscellaneous factors on activity in vitro.
A. Wookey
,
P. Turner
,
J. Greenhalgh
,
M. Eastwood
,
J. Clarke
,
C. Sefton
Clinical Microbiology and Infection
2004
Corpus ID: 28966744
AZD2563, a new oxazolidinone targeted at Gram-positive bacteria, was evaluated and compared with linezolid and other agents…
Expand
2004
2004
Low in vitro selection frequencies of enterococcal and staphylococcal mutants resistant to the oxazolidinone AZD2563.
M. Stockdale
,
L. Tysall
,
Alan P. Johnson
,
D. Livermore
,
N. Woodford
International Journal of Antimicrobial Agents
2004
Corpus ID: 24051511
2002
2002
Anti-anaerobic activity of AZD2563, a new oxazolidinone, compared with eight other agents.
L. Ednie
,
M. Jacobs
,
P. Appelbaum
Journal of Antimicrobial Chemotherapy
2002
Corpus ID: 1149153
The anti-anaerobic activity of AZD2563, a new oxazolidinone, was compared with that of eight other agents against 201 Gram…
Expand
2002
2002
In vitro activity of a novel oxazolidinone, AZD2563, against randomly selected and multiresistant Gram-positive cocci.
Alan P. Johnson
,
M. Warner
,
D. Livermore
Journal of Antimicrobial Chemotherapy
2002
Corpus ID: 11769033
The in vitro activity of AZD2563, a novel oxazolidinone, was assessed against 595 Gram-positive cocci, comprising recent…
Expand
2002
2002
Comparative Activities of the Oxazolidinone AZD2563 and Linezolid against Selected Recent North American Isolates of Streptococcus pneumoniae
S. Baum
,
S. Crawford
,
M. McElmeel
,
C. Whitney
,
J. Jorgensen
Antimicrobial Agents and Chemotherapy
2002
Corpus ID: 7351696
ABSTRACT The activity of AZD2563 against 250 highly resistant pneumococci and 267 drug-susceptible isolates was determined. The…
Expand
2002
2002
In Vitro Evaluation of AZD2563, a Novel Oxazolidinone, against 603 Recent Staphylococcal Isolates
T. Anderegg
,
D. Biedenbach
,
Ronald N. Jones
Antimicrobial Agents and Chemotherapy
2002
Corpus ID: 25767240
ABSTRACT AZD2563, a novel oxazolidinone, and a selection of comparator drugs that included linezolid, erythromycin, clindamycin…
Expand
2002
2002
In vitro evaluation of AZD2563, a new oxazolidinone, tested against beta-haemolytic and viridans group streptococci.
T. Anderegg
,
D. Biedenbach
,
Ronald N. Jones
Journal of Antimicrobial Chemotherapy
2002
Corpus ID: 36427
Linezolid was the first clinically applied agent from the oxazolidinone class, and AZD2563, a new agent, is described here. Five…
Expand
2002
2002
In vitro evaluation of AZD2563, a new oxazolidinone, tested against unusual gram-positive species.
Ronald N. Jones
,
D. Biedenbach
,
T. Anderegg
Diagnostic microbiology and infectious disease
2002
Corpus ID: 24054274
2002
2002
Antipneumococcal activity of AZD2563, a new oxazolidinone, compared with nine other agents.
Mihaela Perić
,
Gengrong Lin
,
Catherine L. Clark
,
M. R. Jacobs
,
P. Appelbaum
Journal of Antimicrobial Chemotherapy
2002
Corpus ID: 23874795
The in vitro activity of AZD2563, a new oxazolidinone, was compared with that of linezolid, vancomycin, quinupristin/dalfopristin…
Expand
2002
2002
In Vitro Activity of the New Oxazolidinone AZD2563 against Enterococci
G. M. Eliopoulos
,
G. M. Eliopoulos
,
C. Wennersten
,
R. Moellering
,
R. Moellering
Antimicrobial Agents and Chemotherapy
2002
Corpus ID: 38108825
ABSTRACT The activity of a new oxazolidinone antimicrobial, AZD2563, was assessed against >500 clinical isolates of enterococci…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE